An ARS-Based, Interactive Session Focused on the Patient with T2D Who Requires Pan-Glycemic (FPG and PPG) Control, is Averse to Multiple Daily Injections, and Needs to Lose Weight and Improve Overall HA1c Levels

An ARS-Based, Interactive Session Focused on the Patient with T2D Who Requires Pan-Glycemic (FPG and PPG) Control, is Averse to Multiple Daily Injections, and Needs to Lose Weight and Improve Overall HA1c Levels


Published

June 28, 2017

Created by

CMEducation Resources symposium

Related Presenters

Juan P. Frias, MD, FACE

Juan P. Frias, MD, FACE

Endocrinology, Diabetes and Metabolism
Clinical Assistant Professor of Medicine
University of California, San Diego
President and Principal Investigator
National Research Institute